about
sameAs
Host defense mechanisms in secondary syphilitic lesions: a role for IFN-gamma-/IL-17-producing CD8+ T cells?Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.Antagonistic effect of the inflammasome on thymic stromal lymphopoietin expression in the skin.In Situ Mapping of Innate Lymphoid Cells in Human Skin: Evidence for Remarkable Differences between Normal and Inflamed Skin.Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease.Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease.Analysis of anti-TNF-induced skin lesions reveals strong Th1 activation with some distinct immunological characteristics.Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case Study.[Skin barrier defects in atopic dermatitis: new treatments?]Methadone-Not a magic bullet in melanoma therapyInterstitial granulomatous dermatitis during talimogen laherparepvec treatmentWhat makes an allergen an allergen? Formyl-peptidyl receptor 3 and lipocalins: At the crossroads of TH2 inductionRapid growth of congenital angioma in an HIV patient with POEMS syndromeType 2 immunity in the skin and lungsClinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre studySubcutaneous White Adipose Tissue of Healthy Young Individuals Harbors a Leukocyte Compartment Distinct from Skin and BloodImmune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
P50
Q34254490-034D9349-FB78-457B-BF76-67818FC69596Q38380834-CC1A7B82-DC45-455C-85D0-A62EB75AA9BAQ39109165-7AB00619-4F78-45A3-9F44-73E6B3EF56D0Q40600425-B75CE7BA-67F2-4ABC-B1D3-0FA1BC1222E7Q41657432-66BAB821-3785-4B0E-9733-824F6C4D9FA4Q42239977-4F253D39-7157-4FF6-8DCA-2B840B03EC55Q49968928-203FAE8D-02EC-47BE-995F-4A0EFD3417B6Q53691603-34624554-C45C-47AB-9971-3EA7FA97EA0CQ83330029-452040F4-EF18-43EF-BE0E-5FBC62520721Q88169971-051A3B11-0D4B-4B38-A319-65D8AD1A0B06Q88211638-05EEF8FF-BABB-4242-AE07-7C688E37F8C6Q91489462-11E1B690-C79D-40FA-8D7D-D69DD1DF44A4Q91587073-1050B701-926E-49CC-AED6-C8182DD07EFCQ92138968-9A7D9CA8-DBF2-40E1-989D-38C03CC0857EQ92752786-7BA09807-18BE-42F7-B394-8AEFE6547C77Q93028312-05FA6267-ACB2-4BBC-935B-75D8D49AF6C9Q94589127-F62CF924-BF38-4D0E-BBCA-8E890786C01B
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-8607-6254
@en
name
Marie-Charlotte Brüggen
@ast
Marie-Charlotte Brüggen
@en
Marie-Charlotte Brüggen
@es
Marie-Charlotte Brüggen
@fr
Marie-Charlotte Brüggen
@nl
type
label
Marie-Charlotte Brüggen
@ast
Marie-Charlotte Brüggen
@en
Marie-Charlotte Brüggen
@es
Marie-Charlotte Brüggen
@fr
Marie-Charlotte Brüggen
@nl
prefLabel
Marie-Charlotte Brüggen
@ast
Marie-Charlotte Brüggen
@en
Marie-Charlotte Brüggen
@es
Marie-Charlotte Brüggen
@fr
Marie-Charlotte Brüggen
@nl
P106
P21
P31
P496
0000-0002-8607-6254